MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer

Drug Resistance Updates · Published 2026-08-01 · DOI 10.1016/j.drup.2026.101463

Authors (7)

Wang Liu, Lily He, Cuncong Zhong, Yuzhuo Wang, Da Zhang, Moben Mirza, Benyi Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Liu, W., He, L., Zhong, C., et al. (2026). MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101463

Related articles

• Transcription Factor Dynamics in Neuroendocrine Prostate Cancer Development. · 2025 · Cites or is cited by this article
• Reappraisal of Neuroendocrine Tumor Classification of the Prostate Gland: Translating Molecular Insights into Clinical Practice · Endocrine Pathology · 2025 · Cites or is cited by this article
• RNA m 1 A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target · Cancer Communications · 2025 · Cites or is cited by this article
• Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression · Drug Resistance Updates · 2026 · Same journal
• Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies · Drug Resistance Updates · 2026 · Same journal
• Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance · Drug Resistance Updates · 2026 · Same journal
• Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma · Drug Resistance Updates · 2026 · Same journal
• ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma · Drug Resistance Updates · 2026 · Same journal
• PRKCA and ABCB1 dual-enriched exosomes are key drivers of drug resistance in chronic myeloid leukemia · Drug Resistance Updates · 2026 · Same journal
• Mechanistic analysis on epigenetic programming of tumor drug resistance · Drug Resistance Updates · 2026 · Same journal